Richard Wilder

From SourceWatch
Jump to navigation Jump to search

"Mr. Wilder is General Counsel and Director of Business Development at the Coalition for Epidemic Preparedness Innovations (CEPI). There he and his team are responsible for drafting and negotiating legal instruments necessary to progress CEPI’s mission and to support its administrative requirements. He and his team also support external engagement with the wide range of actors that form the CEPI coalition. He previously had a similar role in the Global Health Program at the Bill & Melinda Gates Foundation. In that capacity he has responsibility for providing legal support in a range of projects for the development and delivery of drugs, vaccines and diagnostics in the developing world.

"Prior to that, he was Associate General Counsel for Intellectual Property Policy at Microsoft Corporation where he was responsible for defining and driving the company-wide policy in all areas of intellectual property. And prior to that he was a partner in a global law firm, where he specialized in international law. There, he represented countries and companies in international trade disputes – in particular those involving intellectual property.

"He also practiced in the field public health – including on access to existing medicines and the development of new ones, with particular focus on developing country needs. In this connection, he has advised the Global Fund to Fight AIDS, Tuberculosis, and Malaria, the World Health Organization, the Medicines for Malaria Venture, the Global Alliance for TB Drug Development, the U.S. Agency for International Development, and the Bill Melinda Gates Foundation.

"Mr. Wilder is a former Director of the Global Intellectual Property Issues Division of the World Intellectual Property Organization – a specialized agency of the United Nations in Geneva. "[1]

Resources and articles

Related Sourcewatch

References

  1. Coalition for Epidemic Preparedness Innovations Luc Debruyne, organizational web page, accessed April 10, 2020.